Resources

 The latest in cell & gene research, from advanced therapies through to the latest developments in cell & gene research, therapies & manufacturing

Cell Therapy Development

Good Manufacturing Practices: Overcoming Regulatory Approval Hurdles

Securing regulatory approval is often the end goal in the development of a new therapeutic product. But what steps can be taken to avoid some of the common curveballs encountered in the industry?
Tissue Engineering & 3D Models

In Conversation With...Stefan Przyborski, Professor, Durham University

In this video Q&A we discuss Stefan's recent work with bioengineered human tissues and the challenges to adopting 3D cell culture technologies in research.
Tissue Engineering & 3D Models

Apical-Out Organoids: A Novel Strategy to Control the Polarity of Organoids Closing

Genentech are developing several complex gastrointestinal in vitro models, including the innovative apical-out organoids.
Cell & Gene Therapy Manufacturing

Q &A with Shilpi Rajoria

An interview Shilpi Rajoria, Director QC Analytical Testing at Bristol Myers Squibb.
Tissue Engineering & 3D Models

Understanding the Capabilities of 3D Bioprinting for Cell and Gene Therapy

Exploring academic perspectives on 3D bioprinting techniques for cancer and disease indication models.
Tissue Engineering & 3D Models

Advanced and Predictive 3D Cell Culture Models

Elodie Vandenhaute, Project Director at HCS Pharma, leads a discussion group on utilising multi-cell type models to understand diseases, cells, and therapeutic mechanisms.
Upstream & Downstream Bioprocessing

Accelerating Upstream Process Development with Direct CQA and Media Analysis Feedback

Upstream Bioprocess Development.
Cell Line Development & Engineering

Experience the Next Generation in Clonality

Explore the future of single cell seeding.
Tissue Engineering & 3D Models

Using Cancer Organoids to Discover New Therapeutic Targets

The lack of predictive models is a highly limiting factor in the efficacy of projects designed to find new therapeutic targets. Cutting-edge organoid models may be the key to overcoming these challenges and could improve the prediction candidate drug molecules' clinical success.
Cell & Gene Therapy Manufacturing

Overcoming the Challenges in Cell Therapy Manufacturing

Udayanath Aich, Director at Bristol Myers Squibb, leads a Discussion Group on leveraging advanced technologies and biologics to mitigate challenges.
Cell & Gene Therapy Manufacturing

Looking into the Crystal Ball: The Future of Disruptive Cell and Gene Therapy Manufacturing

What will the future hold for autologous cell and gene therapy manufacturing? Tigen Pharma SA, share their predictions on the prospect of disruptive innovation for the industry.

Oxford Global's R&D Key 40 Stories 2022

Download a copy of the R&D Key 40 Stories 2022 eBook today.

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things cell & gene